Artículos relacionados
Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders
JAK inhibitors target specific inflammatory cytokines involved in various inflammatory diseases. Four molecules have been approved for dermatological use: upadacitinib, baricitinib, abrocitinib and topical ruxolitinib. Off-label prescriptions for other dermatological conditions have been reported. We […]
Mental health conditions in Mexico: Diagnosis trends based on hospital records
Objective Analyze spatiotemporal trends in mental disorder diagnoses in Mexico between 2019 and 2023. Design An ecological study was conducted based on records of mental disorder diagnoses in the population aged ≥21 years with social […]
[Translated article] Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19
Hydroxychloroquine is an antimalarial drug with immunomodulatory, anti-inflammatory, antibacterial, and antiviral properties. It has a good safety profile, can be used in children and in pregnant and breastfeeding women, and does not suppress the immune […]
